Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FCB PET/CT in Healthy Volunteers and Invasive Mold Infections
NCT07704333Phase 1Recruiting
- Sponsor
- National Institutes of Health
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 1, open-label trial in invasive fungal infection (IFI) (3 arms), sponsored by National Institutes of Health. Primary endpoint: Standardized Uptake Values at 3 years. Started Jul 2026; status: recruiting.
02
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT07704333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704333.